PHA Classroom banner

PHA Classroom has moved! Visit

>> Back to Recordings

History of PH: Mechanisms and Physiology

December 6, 2013

This interactive discussion on the history of pulmonary hypertension (PH) is the first presentation of a two-part series. It will focus on the evolution of our understanding of the mechanisms and physiology of PH. The webinar will consist of an interview with a panel of experts considered to be among the founders of the modern PH field.

View the second webinar in the series, History of PH: Progress in Clinical Management.

Presenter Information

Bruce Brundage, MD
Emeritus Professor of Medicine
David Geffen University of California, Los Angeles School of Medicine

Bruce H. Brundage, MD, is Emeritus Professor of Medicine at David Geffen UCLA, School of Medicine and served as Chief of Cardiology at Harbor-UCLA Medical Center. He received his MD at UMDNJ–New Jersey Medical School, completed his internship at Tripler Army Medical Center, Honolulu (rotating internship), his internal medicine residency at Fitzsimons Army Medical Center, Denver, and his cardiology fellowship at Letterman Army Medical Center, San Francisco. In 1990, Dr. Brundage accepted the above positions at UCLA and as Scientific Director of the St. Johns Cardiovascular Research Center. Dr. Brundage published over 150 peer-reviewed manuscripts and edited 2 textbooks. Throughout his career he received multiple research grants, and served as PI in the study that first demonstrated the effectiveness of calcium channel-blockers in reducing pulmonary artery pressures. He was the first Chair of PHA’s Scientific Leadership Council and the first physician to Chair PHA’s Board of Trustees.

C. Gregory Elliott, MD
Professor of Medicine
University of Utah School of Medicine

C. Greg Elliott, MD, is Professor of Medicine at the University of Utah School of Medicine and Chairman of the Department of Medicine at Intermountain Medical Center. He received his MD at the University of Maryland School of Medicine. His internship, residency, and Chief Medical Residency were completed at the University of Maryland Hospitals. His pulmonary and critical care fellowship was completed at the University of Utah School of Medicine. His research and patient care focus is pulmonary hypertension and pulmonary vascular diseases. Dr. Elliott aims to advance our understanding and treatment of pulmonary hypertensive disease.  He has helped to develop and test new treatments and to understand the genetics (inheritance) of this disease. Dr. Elliott has authored or co-authored more than 90 original manuscripts in peer reviewed journals, in addition to numerous book chapters, editorials, and invited reviews. He is a past Chair of PHA's Scientific Leadership Council.

Stephen Mathai, MD
Assistant Professor of Medicine
Johns Hopkins University School of Medicine

Stephen C. Mathai, MD, MHS, is Assistant Professor in the Division of Pulmonary and Critical Care at Johns Hopkins University School of Medicine. Dr. Mathai received his MD at Jefferson Medical College, and went on to complete his internship, residency and chief medical residency at Thomas Jefferson University Hospital. He then completed his fellowship in pulmonary and critical care medicine at Johns Hopkins University School of Medicine and his MHS in clinical investigation at Johns Hopkins Bloomberg School of Public Health. He has authored and reviewed many scholarly publications and serves as investigator in many research studies. Dr. Mathai is a current member of PHA’s Scientific Leadership Council.

Lewis Rubin, MD
Emeritus Professor of Medicine
University of California, San Diego School of Medicine

Lewis J. Rubin, MD, is Emeritus Professor of Medicine at the University of California in San Diego, School of Medicine and its emeritus director of Pulmonary and Critical Care. Professor Rubin earned his medical degree from the Albert Einstein College of Medicine, New York, and completed a residency and fellowship at Duke University Medical Center. He has been involved in the basic and clinical investigation of pulmonary vascular diseases for more than 30 years. He has authored over 200 peer-reviewed publications and 70 book chapters, and edited six books on the pulmonary circulation. He has served as Principal Investigator/Steering Committee Chair or Member for the pivotal trials of most of the currently approved medical therapies for PAH. Dr. Rubin previously served as a member of PHA’s Scientific Leadership Council.

FacebookTwitterInstagram iconLinkedInYouTube

For optimal viewing of, please use a standards-compliant browser such as Google Chrome or Firefox.

The information provided on the PHA website is provided for general information only. It is not intended as legal, medical or other professional advice, and should not be relied upon as a substitute for consultations with qualified professionals who are familiar with your individual needs.

801 Roeder Road, Ste. 1000, Silver Spring, MD 20910   Patient-to-Patient Support Line: 1-800-748-7274
    Privacy Policy    Provide Feedback & Report Bugs

Designed by Matrix Group International, Inc.® | © 2016 Pulmonary Hypertension Association. All Rights Reserved.


The National Organization for Rare Disorders (NORD) awarded PHA the Abbey S. Meyers Leadership Award in 2012 for outstanding service to PHA members in advocacy, education and other key areas.